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Cystic hydatidosis (CH) is a worldwide distributed parasitic zoonosis. It is 
considered one of the 17 neglected parasitic tropical diseases, among cysticercosis 
and soil transmitted helminthiases. CH is caused by the larval stage of Echinococcus 
granulosus, a tapeworm that usually infects dogs and other carnivorous animals as 
defi nitive hosts and herbivorous animals and rarely humans as intermediate hosts. 
Main primary localizations are the liver and the lung. In less than 3% they can pri-
marily be present in the spleen. Treatment is mainly surgical, in some cases resulting 
in reoccurrence. In this paper we present the case of a male 55 years old patient who 
underwent a surgical intervention on his spleen for a solitary hydatid cyst as primary 
localization. Fifteen years after the operation the patient presented macroscopic 
 haematuria; routine laboratory fi ndings presented soft eosinophilia, 5%, without 
any other modifi cation. There was found no palpable tumour in the pelvis by rectal 
examination. Abdominal ultrasound investigation revealed a 2×1 cm formation in 
the urinary bladder at the base of the left bladder-wall and a retrovesical, inhomoge-
neous 10×10 cm tumour with multiple septa and transonic zones. Computed tomog-
raphy (CT) scan strongly suggested the presence of a bladder tumour and a hydatid 
cyst. The symptoms caused by the bladder tumour revealed the co-existing non-
symptomatic retrovesical secondary CH, which is a rare complication of splenic 
Echinococcus granulosus infection. Close follow-up and a proper pre- and postop-
erative anti-parasitic medication of the patient could have prevented reoccurrence 
of CH.
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Introduction
Cystic hydatidosis (CH) is a well-known parasitic disease described from 
ancient times. The proof that Echinococcus granulosus causes CH was brought 
by Carl von Siebold. In the year 1853 he reproduced the life cycle of the tapeworm 
by feeding cysts removed from sheep to dogs developing adult cestodes in their 
intestinal tract. The experiment was reproduced by Naunyn in 1863, using cysts 
from humans and feeding them to dogs with the same results [1]. Usually CH is 
well-tolerated by the host, depending on localization and diameter. Cysts grow 
1–2 cm in diameter each year without having a symptomatic character. Main lo-
calizations of CH are the liver (60–70%) and the lungs (30%), only 10% of the 
cases passing these two fi lters. Primary splenic CH is very rare, less than 3% of 
the patients, being resolved usually by classical surgery without any recurrence. 
When complications appear, they manifest as secondary infections, compres-
sion of other organs, rupture in the abdominal cavity causing life-threatening 
generalized anaphylactic reaction or fi stulization to other neighbouring organs, 
especially to the large bowel. For the postoperative prevention four week alben-
dazole treatment and a six-month CT-scan follow-up should be respected [2].
Bladder neoplasms (BN) are considered to be the most frequent cancers of 
the urinary tract [3]. They are the 7th most common malignant tumours in men 
and the 17th most common neoplasms in women. BN occur 3 to 4 times more 
frequent in men and have a higher incidence in developed countries of Europe 
and the USA [4]. A large percent, 70%, of BN reside in the urothelium, causing 
non-muscle invasive bladder cancer [5]. The most infl uencing risk factors for 
developing BN are smoking and occupation, while diet and environmental condi-
tions are less important in its aetiology [6].
The co-existence of bladder neoplasm and secondary retrovesical hy-
datid cyst is very rare in the literature and demands an interdisciplinary profes-
sional team to handle it.
Case report
A 55-year-old male patient presented with intermittent episodes of macro-
scopic haematuria at the urology ward. The patient had no other complaints. 
Physical examination revealed a scar in the left hypochondrium, resulting after 
a surgical intervention, which was performed 15 years ago for a solitary hydatid 
cyst of the spleen. There were no physical or laboratory modifi cations except 
a soft eosinophilia (5%) and a macroscopic haematuria; no tumour mass was 
palpable on rectal examination. Chest radiography described no abnormalities. 
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 Abdominal ultrasound examination revealed a 2×1 cm sized tumour localized at 
the base of the left bladder-wall and a 10×10 cm sized retrovesical inhomogene-
ous cyst with multiple septa and transonic zones suggesting a CH. The abdominal 
CT-scan strongly suggested the bladder tumour and hydatid cyst diagnosis; it also 
revealed a spleen scar as a result of a surgical intervention for a primary CH 
(Fig. 1). The liver and the other abdominal organs were normal.
The strong CT suspicion of a retrovesical hydatid cyst indicated an oral 
treatment with a daily 400 mg dose of albendazole for four weeks. Because of the 
existence of these comorbidities, a CH and a BN, a team constituted of urologists 
and general surgeons resolved the case together.
The main question was: which pathology must be treated fi rst? Because of 
the risk of haematuria, secondary the presence of bladder mass and the possible 
neoplastic character we performed fi rst, a transurethral resection of the bladder 
tumour. After four weeks with an albendazole prophylaxis, the ablation of the 
hydatid cyst was executed. The presence of an important number of daughter 
vesicles, the risk of important haemorrhage (because of the localization of the 
cyst), with secondary anaemia and other possible comorbidities, an open surgery 
technique was indicated (Figs 2 and 3).
Figure 1. CT-scan showing a bladder tumour, retrovesical hydatid cyst, 
and a calcifi ed scar in the spleen
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The removed vesicles underwent parasitological and histological examina-
tions, which confi rmed the diagnosis of hydatidosis. Histopathological examina-
tion of the BN revealed a G2 (tumour grading), low grade malignancy and a pTa 
(non-invasive papillary carcinoma) stadium tumour. There were no complica-
Figure 2. Intraoperatory fi ndings during open surgery
Figure 3. Hydatid vesicles removed from the patient
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tions after the operation and the patient was discharged on the seventh postopera-
tory day with the recommendation to continue the oral treatment with albenda-
zole for another three weeks. For additional treatment of BN instillations with 
BCG were performed, based upon Lahm scheme.
After a six-week period the patient was examined again. CT scan revealed 
no changes in his condition. The postoperative control after 3 months showed no 
evidence of tumour recurrence and no re-occurence of hydatid cyst in the pelvic 
area. Control after one year showed no bladder tumour or hydatid recurrence 
(Fig. 4). The follow-up should continue for at least 3 years.
Discussions
Cystic hydatidosis (CH) is a worldwide distributed parasitic zoonosis 
caused by the larval stage, metacestode, of Echinococcus granulosus. This para-
site affects sheep, cattle and humans as intermediate hosts and dogs, wolves, 
foxes as defi nitive hosts. It is considered one of the 17 neglected parasitic tropical 
diseases; among cysticercosis and soil transmitted helminthiases [9].
Urinary tract localization of hydatid cysts is unusual representing only 
2–4% of the cases [10]. Primary or secondary isolated hydatid cyst with retroves-
ical localization is also rare [11]. Diagnosis usually is based on physical examina-
tion revealing a non-symptomatic mass in the pelvis, completed by laboratory 
Figure 4. CT scan after one year, revealed normal bladder with small scar behind
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fi ndings, such as eosinophilia and specifi c serological tests. X-ray, ultrasound, 
CT and MRI can also help to make the diagnosis, showing eggshell-like calcifi ca-
tions, multiple septa, daughter vesicles in the suspected area which can be repre-
sented by any organ or tissue of the human body [2].
The major concern in the management of pelvic CH is complication due to 
spillage of the highly immunogenic content that may lead to anaphylactic reac-
tions or dissemination by implementation of the spilled scolices, Palanivelu hy-
datid system is a special instrument able to aspirate the cyst without spilling its 
content [12]. If necessary, open surgery is the best choice.
For the management of the BN, a transurethral tumour-removal is rec-
ommended. The extracted materials undergo histopathological examinations. 
In case of BN, they help to defi ne the malignancy grade and guide the postopera-
tive treatment and follow-up. The histological result G2, pTa represents a bladder 
tumour with a low grade of malignancy.
In case of CH, histology offers a 100% correct diagnosis, revealing the 
adventitia, laminated membrane and the germinal inner layer of the hydatid cyst. 
Parasitological examination of the cyst content after centrifuging it, shows the 
presence of protoscolices in the hydatid sand.
Conclusions
We described an infrequent case of co-existing low grade malignant blad-
der tumour and a solitary retrovesical secondary CH in a 55 years old male pa-
tient. Despite an effi cient surgical treatment for a solitary spleen hydatid cyst 15 
years earlier, the patient developed complication by recurrence of CH in the pel-
vic area. If a correct postsurgical specifi c pharmacological treatment had been 
applied, complete healing would have been insured. In case of this patient, the 
secondary pelvic cyst remained silent and was only discovered accidentally when 
the co-existing bladder tumour became symptomatic. CT scan was extremely 
helpful in diagnosis revealing the presence of daughter cysts inside the large for-
mation. The management of this case was individualized based on localization 
and size of the cyst and the presence of co-morbidities.
As far as we know there are very scarce descriptions of similar cases in the 
literature, therefore our case-presentation can be helpful in everyday clinical 
practice.
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